Mahmoud M. Elaasser

Mahmoud M. Elaasser

Auto-generated profile, based on publicly available information

Mahmoud M. Elaasser

Al-Azhar University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in HETEROCYCLES
Verified
Journal Article
Closed access
SRSayed M. Riyadh
Sayed M. Riyadh
SGSobhi M. Gomha
Sobhi M. Gomha
EMElmahdi A. Mahmmoud
Elmahdi A. Mahmmoud
MEMahmoud M. Elaasser
Mahmoud M. Elaasser


6 October 2020 in Molecules
Verified
Journal Article
Open access
PDF file
NZNourah A. Al Zahrani
Nourah A. Al Zahrani
Reda El-ShishtawyReda El-Shishtawy
Reda El-Shishtawy
MEMahmoud M. Elaasser
Mahmoud M. Elaasser
Abdullah M. AsiriAbdullah M. Asiri
Abdullah M. Asiri
Based on reported results for the potential medicinal impact of phenothiazine core, as well as the chalcone skeleton that is widely present in many natural products, together with their reported bioactivities, the present work was aimed at combining both moieties in one molecular skeleton and to synthesize and characterize a novel series of chalone-based phenothiazine derivatives. For this purpose, 2-acetylphenothiazine was N-alkylated, followed by the Claisen-Schmidt reaction to produce the chalcones with good yield. Antioxidant activity, as evaluated by 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging, was assessed to determine if their antioxidant potential was comparable with ascorbic acid, and attributable to the phenothiazine core. Screening anticancer activities of the synthesized chalone-based phenothiazine derivatives against human breast cancer cell line MCF-7 cells, and human hepatocellular carcinoma HepG-2 cells, compared with standard drugs cisplatin and doxorubicin, was evaluated. The results revealed that compounds 4a, 4b, 4d, 4h, 4j, 4k, 4m, 4o, and 4p were good against human hepatocellular carcinoma HepG-2 cells, and among these compounds 4b and 4k were the most effective compounds, with IC50 values of 7.14 μg/mL and 7.6 1 μg/mL, respectively. On the other hand, compounds 4a, 4b, 4k, and 4m were good against human breast cancer cell line MCF-7 cells and, among these compounds, 4k and 4b were the most effective compounds, with IC50 values of 12 μg/mL and 13. 8 μg/mL, respectively. The overall results suggest that these compounds could, potentially, be further modified for the formation of more potent antioxidant and anticancer agents.

1 December 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MAMahmoud F. Abo-Ashour
Mahmoud F. Abo-Ashour
Wagdy Mohamed EldehnaWagdy Mohamed Eldehna
Wagdy Mohamed Eldehna
RGRiham F. George
Riham F. George
MAMarwa Abdel-Aziz
Marwa Abdel-Aziz
MEMahmoud M. Elaasser
Mahmoud M. Elaasser
SASahar M. Abou-Seri
Sahar M. Abou-Seri

1 October 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HIHany Ibrahim
Hany Ibrahim
SASahar M. Abou-Seri
Sahar M. Abou-Seri
MTMuhammet Tanc
Muhammet Tanc
MEMahmoud M. Elaasser
Mahmoud M. Elaasser
HAHatem Abdel-Aziz
Hatem Abdel-Aziz
Claudiu SupuranClaudiu Supuran
Claudiu Supuran